You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • P192 Functional respiratory imaging (fri) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using innovative co-suspension delivery technology (gff mdi) in copd

Citation Tools

Article menu

Download PDFPDF

Biomarkers, imaging and outcomes in COPD
P192 Functional respiratory imaging (fri) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using innovative co-suspension delivery technology (gff mdi) in copd
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
De Backer W, De Backer J, Vos W, et al
P192 Functional respiratory imaging (fri) and lung function assessment of glycopyrronium/formoterol fumarate dihydrate fixed-dose combination delivered using innovative co-suspension delivery technology (gff mdi) in copd
Thorax 2017;72:A186-A188.